Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2018
Price : $35 *
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Otitis media; Pneumococcal infections; Respiratory tract infections
- Focus Pharmacodynamics
- Acronyms PREV-IX_BOOST
- 17 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Oct 2018 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 17 Oct 2018 Planned primary completion date changed from 1 May 2019 to 1 Mar 2020.